The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Age-Related Macular Degeneration
Abstract
Age-related macular degeneration is the leading cause of irreversible blindness in people 50 years of age or older in the developed world. This article reviews the clinical and histopathological features of age-related macular degeneration and its genetics and epidemiology and discusses current management options and research advances.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies have shown that the most established factors are advanced age, cigarette smoking, diet, and race (Coleman et al., 2008; Jager et al., 2008).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Jager et al., 2008
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Research works printed but not linked: 2
- Okamoto H, 2006, Mol Vis, 12, 156
- Chen LJ, 2006, Mol Vis, 12, 1536
Cited by
VEGF in signaling and disease: beyond discovery and development
Apte, R. S., Chen, D. S., & Ferrara, N. (2019) · Cell · doi:10.1016/j.cell.2019.01.021 · Cited by 2,721
“In parallel, it became apparent that VEGF played a cardinal role after development both in the maintenance of physiologic homeostasis and in retinal vascular diseases such as diabetic retinopathy (DR) and AMD (Duh and Aiello, 1999; Jager et al., 2008).”
BackgroundNita, M., & Grzybowski, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3164734 · Cited by 1,448
Ten years of anti-vascular endothelial growth factor therapy
Ferrara, N., & Adamis, A. P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.17 · Cited by 1,030
Bhutto, I., & Lutty, G. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.04.005 · Cited by 1,005
Peripheral vision and pattern recognition: A review
Strasburger, H., Rentschler, I., & Jüttner, M. (2011) · Journal of Vision · doi:10.1167/11.5.13 · Cited by 943
Metadata
- Authors
- Jager, R. D., Mieler, W. F., & Miller, J. W.
- Affiliations
- University of Chicago (US)
- Harvard University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-06-12
- Volume
- 358
- Issue
- 24
- Pages
- 2606-2617
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4256101427
- Semantic Scholar
- bf402b8bf7f7aa7ce6609059a6c299358816a1ae
- Cited by
- 1,379
- References
- 92
- Citations by year
- 2026: 31 · 2025: 48 · 2024: 40 · 2023: 72 · 2022: 88 · 2021: 86 · 2020: 109 · 2019: 116 · 2018: 95 · 2017: 112 · 2016: 85 · 2015: 85 · 2014: 89 · 2013: 75 · 2012: 86
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- age-related macular degeneration, histopathology, disease management, research advances
- MeSH terms
- Bevacizumab, Ranibizumab, Antibodies, Monoclonal, Antioxidants, Combined Modality Therapy, Diet, Humans, Macular Degeneration, Photochemotherapy, Retina, Risk Factors, Genetic Therapy, Injections, Intralesional, Retinal Drusen, Smoking Cessation, Laser Coagulation, Disease Progression, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Age-Related Macular Degeneration. https://app.cochat.ai/papers/10.1056/nejmra0801537
- The paper
- Jager, R. D., Mieler, W. F., & Miller, J. W. (2008). Age-Related Macular Degeneration. New England Journal of Medicine. https://doi.org/10.1056/nejmra0801537
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.